Literature DB >> 31324344

Analysis of the RIMDAMAL trial.

John Bradley1, Lawrence H Moulton2, Richard Hayes3.   

Abstract

Mesh:

Substances:

Year:  2019        PMID: 31324344     DOI: 10.1016/S0140-6736(19)31663-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  The use of islands and cluster-randomized trials to investigate vector control interventions: a case study on the Bijagós archipelago, Guinea-Bissau.

Authors:  Robert T Jones; Elizabeth Pretorius; Thomas H Ant; John Bradley; Anna Last; James G Logan
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2020-12-28       Impact factor: 6.237

Review 2.  Broadening the range of use cases for ivermectin - a review of the evidence.

Authors:  Christian Kositz; John Bradley; Harry Hutchins; Anna Last; Umberto D'Alessandro; Michael Marks
Journal:  Trans R Soc Trop Med Hyg       Date:  2022-03-02       Impact factor: 2.455

3.  Design and analysis of a 2-year parallel follow-up of repeated ivermectin mass drug administrations for control of malaria: Small sample considerations for cluster-randomized trials with count data.

Authors:  Conner L Jackson; Kathryn Colborn; Dexiang Gao; Sangeeta Rao; Hannah C Slater; Sunil Parikh; Brian D Foy; John Kittelson
Journal:  Clin Trials       Date:  2021-07-03       Impact factor: 2.486

4.  Ivermectin treatment in humans for reducing malaria transmission.

Authors:  Dziedzom K de Souza; Rebecca Thomas; John Bradley; Clemence Leyrat; Daniel A Boakye; Joseph Okebe
Journal:  Cochrane Database Syst Rev       Date:  2021-06-29

5.  A Roadmap for the Development of Ivermectin as a Complementary Malaria Vector Control Tool.

Authors:  Peter Billingsley; Fred Binka; Carlos Chaccour; Brian Foy; Silvia Gold; Matiana Gonzalez-Silva; Julie Jacobson; George Jagoe; Caroline Jones; Patrick Kachur; Kevin Kobylinski; Anna Last; James V Lavery; David Mabey; David Mboera; Charles Mbogo; Ana Mendez-Lopez; N. Regina Rabinovich; Sarah Rees; Frank Richards; Cassidy Rist; Jessica Rockwood; Paula Ruiz-Castillo; Jetsumon Sattabongkot; Francisco Saute; Hannah Slater; Andrew Steer; Kang Xia; Rose Zullinger
Journal:  Am J Trop Med Hyg       Date:  2020-02       Impact factor: 2.345

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.